6533b872fe1ef96bd12d3922
RESEARCH PRODUCT
Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cells
Carsten Müller-tidowFlorian H HeidelThomas KindlerThomas FischerMarie-christine WagnerTina M. SchnöderDaniel B. LipkaDaniel B. LipkaMarek DziadoszMirle SchemionekMirle SchemionekJunia V. MeloJunia V. MeloSteffen KoschmiederSteffen Koschmiedersubject
Drugs and DevicesDrug Research and DevelopmentTime Factorsmedicine.drug_classChronic Myeloid LeukemiaIntracellular Spacelcsh:MedicineApoptosisPharmacologyPiperazinesTyrosine-kinase inhibitorHematologic Cancers and Related DisordersCell Line TumorLeukemia Myelogenous Chronic BCR-ABL Positivehemic and lymphatic diseasesLeukemiasmedicineHumansAnnexin A5Proto-Oncogene Proteins c-abllcsh:ScienceProtein Kinase InhibitorsMyeloproliferative DisordersMultidisciplinaryABLDose-Response Relationship DrugCaspase 3Chemistrylcsh:RBiological activityImatinibHematologyrespiratory tract diseasesDasatinibKineticsPyrimidinesImatinib mesylatePharmacodynamicsBenzamidesImatinib MesylateMedicineATP-Binding Cassette Transporterslcsh:QDrug Screening Assays AntitumorSignal transductionIntracellularResearch ArticleSignal Transductionmedicine.drugdescription
PLoS one 7(7), e40853 (2012). doi:10.1371/journal.pone.0040853
year | journal | country | edition | language |
---|---|---|---|---|
2012-07-01 |